Results 41 to 50 of about 6,098 (220)

Psychedelic-Assisted Psychotherapy: When Two Traditions Meet

European Psychiatry, 2022
Introduction After a long moratorium since the Controlled Substances Act was passed in 1970, there has been a resurgence of research on the potential therapeutic benefits of psychedelic (PE) compounds. It has been widely believed that the PE effect is a
E. Frecska, A. Kazai, P. Bokor
doaj   +1 more source

Psychological variables implied in the therapeutic effect of ayahuasca: A contextual approach [PDF]

, 2018
Ayahuasca is a psychedelic decoction originating from Amazonia. The ayahuasca-induced introspective experience has been shown to have potential benefits in the treatment of several pathologies, to protect mental health and to improve neuropsychological ...
Alcázar Córcoles, Miguel Ángel, Bouso, José Carlos, Franquesa, Alba, Gandy, Sam, Sainz-Cort, Alberto, Soler, Joaquim   +5 more
core   +1 more source

Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases [PDF]

, 2014
A double-blind, randomized, active placebo-controlled pilot study was conducted to examine safety and efficacy of lysergic acid diethylamide (LSD)-assisted psychotherapy in 12 patients with anxiety associated with life-threatening diseases.
Brenneisen, Rudolf, Doblin, Rick, Gasser, Peter, Holstein, Dominique, Michel, Yvonne, Passie, Torsten, Yazar-Klosinski, Berra   +6 more
core   +2 more sources

Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression

Frontiers in Pharmacology, 2022
Background: Across psychotherapeutic frameworks, the strength of the therapeutic alliance has been found to correlate with treatment outcomes; however, its role has never been formally assessed in a trial of psychedelic-assisted therapy.
Roberta Murphy, Roberta Murphy, Hannes Kettner, Rick Zeifman, Rick Zeifman, Bruna Giribaldi, Laura Kartner, Jonny Martell, Jonny Martell, Tim Read, Ashleigh Murphy-Beiner, Ashleigh Murphy-Beiner, Michelle Baker-Jones, David Nutt, David Erritzoe, Rosalind Watts, Robin Carhart-Harris, Robin Carhart-Harris   +17 more
doaj   +1 more source

Ethical and legal issues in psychedelic harm reduction and integration therapy

Harm Reduction Journal, 2021
Psychedelic-assisted therapy may represent an upcoming paradigm shift in the treatment of mental health problems as recent clinical trials have demonstrated strong evidence of their therapeutic benefits.
Brian Pilecki, Jason B. Luoma, Geoff J. Bathje, Joseph Rhea, Vilmarie Fraguada Narloch   +4 more
doaj   +1 more source

Self-Medication for Chronic Pain Using Classic Psychedelics: A Qualitative Investigation to Inform Future Research

Frontiers in Psychiatry, 2021
Background: Chronic Pain is among the leading causes of disability worldwide with up to 60% of patients suffering from comorbid depression. Psychedelic-assisted therapy has recently been found effective in treating a host of mental health issues ...
Julia Bornemann, James B. Close, Meg J. Spriggs, Robin Carhart-Harris, Robin Carhart-Harris, Leor Roseman   +5 more
doaj   +1 more source

Virtual reality and psychedelics: new perspectives and new possibilities in the treatment of alcohol use disorder

Frontiers in Psychiatry
Psychedelic-assisted therapy is a remarkably promising treatment for substance use disorders and for alcohol use disorder (AUD) in particular. Research supporting psychedelics as a safe and effective pharmacotherapy for AUD and its comorbid psychiatric ...
Scott Matthews, Scott Matthews, Antonino Greco, Antonino Greco, Antonino Greco, Antonino Greco, Clara Rastelli, Clara Rastelli, Clara Rastelli, Anahita Bassir Nia, Anahita Bassir Nia, Anahita Bassir Nia   +11 more
doaj   +1 more source

Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder [PDF]

, 2018
The present paper discusses the current literature with regard to substance-assisted psychotherapy with Methylenedioxymethamphetamine (MDMA) for posttraumatic stress disorder (PTSD).
Lommen, Miriam J.J., Thal, Sascha B.
core   +1 more source

Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review. [PDF]

, 2023
With the Food and Drug Administration designation in 2017 of 3,4-methylenedioxymethamphetamine (MDMA) as a breakthrough therapy in post-traumatic stress disorder and psilocybin in treatment-resistant depression, psychedelic drugs have continued to garner
Fonseka, Lakshan, Woo, Benjamin
core   +1 more source

Psychedelic‐assisted therapy for functional neurological disorders: A theoretical framework and review of prior reports

Pharmacology Research & Perspectives, 2020
Functional neurological disorders (FNDs), which are sometimes also referred to as psychogenic neurological disorders or conversion disorder, are common disabling neuropsychiatric disorders with limited treatment options. FNDs can present with sensory and/
Benjamin Stewart, Jon G. Dean, Adriana Koek, Jason Chua, Rafael Wabl, Kayla Martin, Naveed Davoodian, Christopher Becker, Mai Himedan, Amanda Kim, Roger Albin, Kelvin L. Chou, Vikas Kotagal   +12 more
doaj   +1 more source